EUVIMEDEUVIMED entdecken
Crossref

Ceramide test in patients with erectile dysfunction to assess cardiovascular risk

Andres Guillen Lozoya iD, Mihai Dumbrava, Milad Bonakdarhashemi, Jayson Kemble, Sevann Helo, Matthew Ziegelmann, Scott Collins, Vlad Vasile, Stephen Kopecky, Tobias Köhler

The Journal of Sexual Medicine · 2025

DOI: 10.1093/jsxmed/qdaf182 ↗

Kurz gefasst

Fachartikel in der Zeitschrift The Journal of Sexual Medicine, 2025. Verfasst von Andres Guillen Lozoya und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Urology, Mayo Clinic Rochester, Rochester, Minnesota, 55905, United States. Hauptthemen laut MEDLINE: Ceramides, Erectile Dysfunction, Cardiovascular Diseases. Die Arbeit nennt 34 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Erectile dysfunction (ED) is a known precursor and sequela of cardiovascular disease (CVD), with ED severity predicting CVD severity.

Aim

This study aimed to evaluate the utility of ceramide levels in patients with ED.

Methods

We initiated ceramide testing in all patients with ED. We retrospectively analyzed ceramide levels from electronic records and stratified by severity of symptoms using the erectile function domain of the International Index of Erectile Function (IIEF). Outcomes The study aimed to determine whether abnormal ceramide levels were associated with ED severity and increased cardiovascular risk.

Results

Three hundred and fifty-four patients were reviewed, of whom 253 (71.5%) had moderate or higher ED. A statistically significant difference in abnormal ceramide values was found in patients with moderate to severe symptoms, and the odds of getting an abnormal ceramide test were increased based on the IIEF scoring alone (odds ratio [OR] 2.3 [1.04-5.12]; P-value = .034). Clinical Implications Serum ceramide testing could be beneficial in identifying cardiovascular risk in men with ED, potentially prompting cardiac referrals and lifestyle modifications. Strengths and Limitations The strengths of this study include a large sample size and the use of a well-established scale, while the limitations include the retrospective nature of the study and the need for further research to validate the findings.

Conclusion

Patients undergoing management for ED may benefit from serum ceramide testing and subsequent cardiac referral.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

CeramidesErectile DysfunctionCardiovascular DiseasesHumansMaleRetrospective StudiesMiddle AgedAdultRisk AssessmentHeart Disease Risk FactorsSeverity of Illness IndexAged

Stichwörter der Autor:innen

cardiovascularceramideerectile dysfunctionriskscreening

Substanzen

Ceramides

Autor:innen und Institutionen

  • Department of Urology, Mayo Clinic Rochester, Rochester, Minnesota, 55905, United States.
  • Mayo Clinic Alix School of Medicine, Rochester, Minnesota, 55905, United States.
  • Department of Urology, University of Nebraska Medical Center, Omaha, Nebraska, 68198, United States.
  • Department of Cardiology, Mayo Clinic Rochester, Rochester, Minnesota, 55905, United States.

ORCID-Profile: Andres Guillen Lozoya

Zitieren

APA

Guillen Lozoya, A., Dumbrava, M., Bonakdarhashemi, M., Kemble, J., Helo, S., Ziegelmann, M., Collins, S., Vasile, V., Kopecky, S., & Köhler, T. (2025). Ceramide test in patients with erectile dysfunction to assess cardiovascular risk. The Journal of Sexual Medicine. https://doi.org/10.1093/jsxmed/qdaf182

Vancouver

Guillen Lozoya A, Dumbrava M, Bonakdarhashemi M, Kemble J, Helo S, Ziegelmann M, et al. Ceramide test in patients with erectile dysfunction to assess cardiovascular risk. The Journal of Sexual Medicine. 2025. doi:10.1093/jsxmed/qdaf182

BibTeX
@article{GuillenLozoya2025,
  author = {Guillen Lozoya, Andres and Dumbrava, Mihai and Bonakdarhashemi, Milad and Kemble, Jayson and Helo, Sevann and Ziegelmann, Matthew and Collins, Scott and Vasile, Vlad and Kopecky, Stephen and Köhler, Tobias},
  title = {Ceramide test in patients with erectile dysfunction to assess cardiovascular risk},
  journal = {The Journal of Sexual Medicine},
  year = {2025},
  doi = {10.1093/jsxmed/qdaf182}
}
Kostenlos starten →